Cargando…

Evaluation of a lanthanide nanoparticle‐based contrast agent for microcomputed tomography of porous channels in subchondral bone

Osteoarthritis (OA) is a chronic joint disease that causes disability and pain. The osteochondral interface is a gradient tissue region that plays a significant role in maintaining joint health. It has been shown that during OA, increased neoangiogenesis creates porous channels at the osteochondral...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, Mateus O., Kirkwood, Nicholas, Mulvaney, Paul, Ellis, Amanda V., Stok, Kathryn S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084061/
https://www.ncbi.nlm.nih.gov/pubmed/35524421
http://dx.doi.org/10.1002/jor.25361
_version_ 1785021656159223808
author Silva, Mateus O.
Kirkwood, Nicholas
Mulvaney, Paul
Ellis, Amanda V.
Stok, Kathryn S.
author_facet Silva, Mateus O.
Kirkwood, Nicholas
Mulvaney, Paul
Ellis, Amanda V.
Stok, Kathryn S.
author_sort Silva, Mateus O.
collection PubMed
description Osteoarthritis (OA) is a chronic joint disease that causes disability and pain. The osteochondral interface is a gradient tissue region that plays a significant role in maintaining joint health. It has been shown that during OA, increased neoangiogenesis creates porous channels at the osteochondral interface allowing the transport of molecules related to OA. Importantly, the connection between these porous channels and the early stages of OA development is still not fully understood. Microcomputed tomography (microCT) offers the ability to image the porous channels at the osteochondral interface, however, a contrast agent is necessary to delineate the different X‐ray attenuations of the tissues. In this study BaYbF(5)‐SiO(2) nanoparticles are synthesized and optimized as a microCT contrast agent to obtain an appropriate contrast attenuation for subsequent segmentation of structures of interest, that is, porous channels, and mouse subchondral bone. For this purpose, BaYbF(5) nanoparticles were synthesized and coated with a biocompatible silica shell (SiO(2)). The optimized BaYbF(5)‐SiO(2) 27 nm nanoparticles exhibited the highest average microCT attenuation among the biocompatible nanoparticles tested. The BaYbF(5)‐SiO(2) 27 nm nanoparticles increased the mean X‐ray attenuation of structures of interest, for example, porous channel models and mouse subchondral bone. The BaYbF(5)‐SiO(2) contrast attenuation was steady after diffusion into mouse subchondral bone. In this study, we obtained for the first time, the average microCT attenuation of the BaYbF(5)‐SiO(2) nanoparticles into porous channel models and mouse subchondral bone. In conclusion, BaYbF(5)‐SiO(2) nanoparticles are a potential contrast agent for imaging porous channels at the osteochondral interface using microCT.
format Online
Article
Text
id pubmed-10084061
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-100840612023-04-11 Evaluation of a lanthanide nanoparticle‐based contrast agent for microcomputed tomography of porous channels in subchondral bone Silva, Mateus O. Kirkwood, Nicholas Mulvaney, Paul Ellis, Amanda V. Stok, Kathryn S. J Orthop Res Research Articles Osteoarthritis (OA) is a chronic joint disease that causes disability and pain. The osteochondral interface is a gradient tissue region that plays a significant role in maintaining joint health. It has been shown that during OA, increased neoangiogenesis creates porous channels at the osteochondral interface allowing the transport of molecules related to OA. Importantly, the connection between these porous channels and the early stages of OA development is still not fully understood. Microcomputed tomography (microCT) offers the ability to image the porous channels at the osteochondral interface, however, a contrast agent is necessary to delineate the different X‐ray attenuations of the tissues. In this study BaYbF(5)‐SiO(2) nanoparticles are synthesized and optimized as a microCT contrast agent to obtain an appropriate contrast attenuation for subsequent segmentation of structures of interest, that is, porous channels, and mouse subchondral bone. For this purpose, BaYbF(5) nanoparticles were synthesized and coated with a biocompatible silica shell (SiO(2)). The optimized BaYbF(5)‐SiO(2) 27 nm nanoparticles exhibited the highest average microCT attenuation among the biocompatible nanoparticles tested. The BaYbF(5)‐SiO(2) 27 nm nanoparticles increased the mean X‐ray attenuation of structures of interest, for example, porous channel models and mouse subchondral bone. The BaYbF(5)‐SiO(2) contrast attenuation was steady after diffusion into mouse subchondral bone. In this study, we obtained for the first time, the average microCT attenuation of the BaYbF(5)‐SiO(2) nanoparticles into porous channel models and mouse subchondral bone. In conclusion, BaYbF(5)‐SiO(2) nanoparticles are a potential contrast agent for imaging porous channels at the osteochondral interface using microCT. John Wiley and Sons Inc. 2022-05-19 2023-02 /pmc/articles/PMC10084061/ /pubmed/35524421 http://dx.doi.org/10.1002/jor.25361 Text en © 2022 The Authors. Journal of Orthopaedic Research® published by Wiley Periodicals LLC on behalf of Orthopaedic Research Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Silva, Mateus O.
Kirkwood, Nicholas
Mulvaney, Paul
Ellis, Amanda V.
Stok, Kathryn S.
Evaluation of a lanthanide nanoparticle‐based contrast agent for microcomputed tomography of porous channels in subchondral bone
title Evaluation of a lanthanide nanoparticle‐based contrast agent for microcomputed tomography of porous channels in subchondral bone
title_full Evaluation of a lanthanide nanoparticle‐based contrast agent for microcomputed tomography of porous channels in subchondral bone
title_fullStr Evaluation of a lanthanide nanoparticle‐based contrast agent for microcomputed tomography of porous channels in subchondral bone
title_full_unstemmed Evaluation of a lanthanide nanoparticle‐based contrast agent for microcomputed tomography of porous channels in subchondral bone
title_short Evaluation of a lanthanide nanoparticle‐based contrast agent for microcomputed tomography of porous channels in subchondral bone
title_sort evaluation of a lanthanide nanoparticle‐based contrast agent for microcomputed tomography of porous channels in subchondral bone
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10084061/
https://www.ncbi.nlm.nih.gov/pubmed/35524421
http://dx.doi.org/10.1002/jor.25361
work_keys_str_mv AT silvamateuso evaluationofalanthanidenanoparticlebasedcontrastagentformicrocomputedtomographyofporouschannelsinsubchondralbone
AT kirkwoodnicholas evaluationofalanthanidenanoparticlebasedcontrastagentformicrocomputedtomographyofporouschannelsinsubchondralbone
AT mulvaneypaul evaluationofalanthanidenanoparticlebasedcontrastagentformicrocomputedtomographyofporouschannelsinsubchondralbone
AT ellisamandav evaluationofalanthanidenanoparticlebasedcontrastagentformicrocomputedtomographyofporouschannelsinsubchondralbone
AT stokkathryns evaluationofalanthanidenanoparticlebasedcontrastagentformicrocomputedtomographyofporouschannelsinsubchondralbone